• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Phys Chem Lett. Novel Coronavirus Polymerase and Nucleotidyl-transferase Structures: Potential to Target New Outbreaks

tetano

Editor, Senior Moderator
J Phys Chem Lett. 2020 May 11. doi: 10.1021/acs.jpclett.0c00571. [Epub ahead of print]
Novel Coronavirus Polymerase and Nucleotidyl-transferase Structures: Potential to Target New Outbreaks.


Zhang W, Stephen P, Th?riault JF, Wang R, Lin SX.

Abstract

The pandemic outbreak of a new coronavirus (CoV), SARS-CoV-2, has captured the world's attention, demonstrating that CoVs induce a continuous global threat. As this is a highly contagious virus, it is imperative to understand RNA-dependent-RNA-polymerase (RdRp), the key component in virus replication. Although the SARS-CoV-2 genome shares 80% sequence identity with severe acute respiratory syndrome (SARS) CoV, their RdRps and nucleotidyl-transferases (NiRAN) share 98.1% and 93.2% identity, respectively. Sequence alignment of six coronaviruses demonstrated higher identity among their RdRps (60.9-98.1%) and lower identity among their Spike proteins (27-77%). Thus, a 3D structural model of RdRp, NiRAN, nsp7 and nsp8 of SARS-CoV-2 was generated by modelling starting from the SARS counterpart structures. Furthermore, we demonstrate the binding poses of three viral RdRp inhibitors: Galidesivir, Favipiravir, and Penciclovir, which was recently reported to have clinical significance for SARS-CoV-2. The network of interactions established by these drug molecules affirm their efficacy to inhibit viral RNA replication and provide an insight into their structure-based rational optimization for SARS-CoV-2 inhibition.



PMID:32392072DOI:10.1021/acs.jpclett.0c00571
 
Back
Top Bottom